Results 151 to 160 of about 38,316 (201)

Assessing the clinical impact of albumin infusion in critically ill ICU patients with acute myocardial infarction and hypoalbuminemia: a retrospective propensity score-matched cohort study. [PDF]

BMC Cardiovasc Disord
Ding Y, Wang K, Xu D, Xu X, Shen Z, Huang X, Huang D.   +6 more
europepmc   +1 more source

Torsemide and warfarin: A cautionary case of altered international normalized ratio and bleeding risk.

Indian J Pharmacol
Mohammed VH, Ranjana SR, Kumar AS.
europepmc   +1 more source

Evaluation of diuretic therapy response in patients with pulmonary edema in the emergency department using the Reverse-FALLS protocol: A prospective observational study. [PDF]

Medicine (Baltimore)
Koç ÖF, Balci EB, Cander B, Taslidere B, Sönmez E.   +4 more
europepmc   +1 more source

Urine Olfactomedin 4 Predicts Furosemide Response and Kidney Replacement Therapy in Critically Ill Children. [PDF]

Crit Care Explor
Hasson DC, Clover-Brown I, Zepeda-Orozco D, Pascal E, Martin SD, Krallman K, Kempton KM, Bennett A, Muszynski J, Lutmer J, Sargel C, Devarajan P, Standage SW, Alder MN, Goldstein SL.   +14 more
europepmc   +1 more source

Predictors of 30-day hospitalization in patients with worsening heart failure receiving outpatient intravenous diuretics. [PDF]

PLoS One
van Maarschalkerwaart WA, Wierda E, de Boer D, Jonkman NH, Boersma E, Brugts JJ, van Heerebeek L.   +6 more
europepmc   +1 more source

Decongestion in chronic heart failure. [PDF]

JRSM Cardiovasc Dis
Laura A, Serban M.
europepmc   +1 more source

Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI). [PDF]

ESC Heart Fail
González González J, Górriz Magaña J, Llàcer P, Fort Pal A, Trullàs JC, Zegrí-Reiriz I, Díez-Villanueva P, Esteban Fernandez A, Pertejo Manzano L, Méndez Fernández AB, Caravaca Pérez P, López-Azor JC, Martínez R, D'Amato M, Fernández Pascual C, Ruiz-Ruiz E, Pérez Pisón E, Berenguel Anter M, Cobo Marcos M.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bumetanide and furosemide

Clinical Pharmacology and Therapeutics, 1983
We assessed the response to and handling of furosemide and bumetanide in 30 experiments with the former and 46 with the latter in normal subjects. Oral doses of furosemide (20, 40, and 80 mg) were used, and subjects received oral doses of 0.5, 1, and 2 mg bumetanide and intravenous doses of 0.5 and 1 mg bumetanide.
D C, Brater, P, Chennavasin, B, Day, A, Burdette, S, Anderson   +4 more
openaire   +2 more sources

Kinetics and dynamics of furosemide and slow-acting furosemide

Clinical Pharmacology and Therapeutics, 1982
Bioavailability and dynamics of a sustained-release preparation of furosemide (FR, 60 mg) were compared with those of a conventional tablet (F, 40 mg). The preparations were given to 12 healthy subjects in a study of crossover randomized design once daily for a week.
openaire   +2 more sources